(Q47404782)

15 January 2018

title

The role of Bcl-2 family members in the progression of cutaneous melanoma (English)

1 reference

PubMed ID

14598887

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14598887

28 March 2024

1 reference

10.1023/A:1025874502181

https://api.crossref.org/works/10.1023/A:1025874502181

28 March 2024

author name string

Gang Li

series ordinal

2

1 reference

15 January 2018

Jason A. Bush

series ordinal

1

1 reference

PubMed ID

14598887

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14598887

28 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

PubMed ID

14598887

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14598887

28 March 2024

publication date

1 January 2003

1 reference

15 January 2018

Clinical & Experimental Metastasis

published in

1 reference

15 January 2018

volume

20

1 reference

15 January 2018

page(s)

531-539

1 reference

15 January 2018

issue

6

1 reference

15 January 2018

https://scigraph.springernature.com/pub.10.1023/a:1025874502181

exact match

0 references

cites work

Integrin alpha(v)beta3 promotes M21 melanoma growth in human skin by regulating tumor cell survival

1 reference

12 December 2020

bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death

1 reference

12 December 2020

Immunohistochemical markers for distinguishing Spitz nevi from malignant melanomas

1 reference

12 December 2020

Bcl-2 overexpression in human melanoma cells increases angiogenesis through VEGF mRNA stabilization and HIF-1-mediated transcriptional activity

1 reference

12 December 2020

Tissue microarray-based analysis shows phospho-beta-catenin expression in malignant melanoma is associated with poor outcome

1 reference

12 December 2020

Tumor necrosis factor-alpha-promoted expression of Bcl-2 and inhibition of mitochondrial cytochrome c release mediate resistance of mature dendritic cells to melanoma-induced apoptosis.

1 reference

12 December 2020

Peptides derived from BH3 domains of Bcl-2 family members: a comparative analysis of inhibition of Bcl-2, Bcl-x(L) and Bax oligomerization, induction of cytochrome c release, and activation of cell death

1 reference

12 December 2020

Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma

1 reference

12 December 2020

Expression of apoptosis regulators in cutaneous malignant melanoma

1 reference

12 December 2020

Nitric oxide-mediated apoptosis of K-1735 melanoma cells is associated with downregulation of Bcl-2

1 reference

12 December 2020

Components of the Rb pathway are critical targets of UV mutagenesis in a murine melanoma model

1 reference

12 December 2020

bcl-2 expression in primary malignancies of the skin

1 reference

12 December 2020

Bcl-2 expression in human melanocytes and melanocytic tumors

1 reference

12 December 2020

bcl-2 expression in melanocytic nevi. Insights into the biology of dermal maturation

1 reference

12 December 2020

Transducible peptide therapy for uveal melanoma and retinoblastoma

1 reference

12 December 2020

Ki67 protein: the immaculate deception?

1 reference

12 December 2020

Roles of activated Src and Stat3 signaling in melanoma tumor cell growth

1 reference

12 December 2020

The bisphosphonate pamidronate induces apoptosis in human melanoma cells in vitro.

1 reference

12 December 2020

Subcellular trafficking of antisense oligonucleotides and down-regulation of bcl-2 gene expression in human melanoma cells using a fusogenic liposome delivery system

1 reference

12 December 2020

Cisplatin induces the proapoptotic conformation of Bak in a deltaMEKK1-dependent manner

1 reference

12 December 2020

Chemosensitisation of malignant melanoma by BCL2 antisense therapy

1 reference

12 December 2020

Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends

1 reference

12 December 2020

Epidemiology of melanoma

1 reference

12 December 2020

Expression of Bcl-2 family members in human melanocytes, in melanoma metastases and in melanoma cell lines

1 reference

12 December 2020

Immunohistochemical expression of BCL-2 in melanomas and intradermal nevi

1 reference

12 December 2020

Expression and targeting of the apoptosis inhibitor, survivin, in human melanoma

1 reference

12 December 2020

Quercetin inhibits the invasion and mobility of murine melanoma B16-BL6 cells through inducing apoptosis via decreasing Bcl-2 expression

1 reference

12 December 2020

Activity of a novel bcl-2/bcl-xL-bispecific antisense oligonucleotide against tumors of diverse histologic origins.

1 reference

12 December 2020

Antitumor effect of G3139 Bcl-2 antisense oligonucleotide is independent of its immune stimulation by CpG motifs in SCID mice

1 reference

12 December 2020

Breaking the mitochondrial barrier

1 reference

12 December 2020

Different patterns of cell proliferation and death and oncogene expression in cutaneous malignant melanoma.

1 reference

12 December 2020

Down-regulation of Bcl-2 and Bcl-xL expression with bispecific antisense treatment in glioblastoma cell lines induce cell death.

1 reference

12 December 2020

Uveal melanoma: natural history and treatment options for metastatic disease.

1 reference

12 December 2020

Immunohistochemical analysis of Bcl-2 protein regulation in cutaneous melanoma.

1 reference

12 December 2020

Human melanocytes and melanoma cells constitutively express the Bcl-2 proto-oncogene in situ and in cell culture.

1 reference

12 December 2020

bcl-2 protein expression in cutaneous malignant melanoma and benign melanocytic nevi.

1 reference

12 December 2020

Farnesyl thiosalicylic acid inhibits the growth of melanoma cells through a combination of cytostatic and pro-apoptotic effects

1 reference

12 December 2020

Relative resistance of fresh isolates of melanoma to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis.

1 reference

12 December 2020

Keratinocytes regulate melanocyte number in human fetal and neonatal skin equivalents

1 reference

12 December 2020

Accelerated disappearance of melanocytes in bcl-2-deficient mice

1 reference

12 December 2020

Immunohistochemical study of 49 cutaneous melanomas: p53, PCNA, Bcl-2 expression and multidrug resistance.

1 reference

12 December 2020

bcl-2 protein expression in melanocytic neoplasms of the skin.

1 reference

12 December 2020

Bcl2 and Bax expression in naevi and melanomas and their relation to ploidy status and proliferation

1 reference

12 December 2020

Formation of nuclear Bax/p53 complexes is associated with chemotherapy induced apoptosis

1 reference

12 December 2020

Bcl-2 expression in malignant melanoma and its prognostic significance

1 reference

12 December 2020

Childhood sun exposure as a risk factor for melanoma: a systematic review of epidemiologic studies

1 reference

12 December 2020

Malignant melanoma: the role of radiation therapy revisited

1 reference

12 December 2020

Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo.

1 reference

12 December 2020

Interactions among members of the Bcl-2 protein family analyzed with a yeast two-hybrid system.

1 reference

12 December 2020

Cleavage of Bcl-2 in oxidant- and cisplatin-induced apoptosis of human melanoma cells

1 reference

12 December 2020

Skin cancer and solar UV radiation

1 reference

12 December 2020

Bcl2 regulation by the melanocyte master regulator Mitf modulates lineage survival and melanoma cell viability

1 reference

12 December 2020

Bcl-2 family of proteins: life-or-death switch in mitochondria

1 reference

12 December 2020

The new melanoma staging system

1 reference

12 December 2020

Tissue microarrays are an effective quality assurance tool for diagnostic immunohistochemistry

1 reference

12 December 2020

Anti-cell death activity promotes pulmonary metastasis of melanoma cells

1 reference

12 December 2020

Induction of apoptosis in prostate carcinoma cells by BH3 peptides which inhibit Bak/Bcl-2 interactions

1 reference

12 December 2020

A recombinant adenovirus expressing wild-type Bax induces apoptosis in prostate cancer cells independently of their Bcl-2 status and androgen sensitivity

1 reference

12 December 2020

The Fas signaling pathway: more than a paradigm

1 reference

12 December 2020

Bcl-2 and bcl-xL antisense oligonucleotides induce apoptosis in melanoma cells of different clinical stages

1 reference

12 December 2020

The histogenesis and biologic behavior of primary human malignant melanomas of the skin

1 reference

12 December 2020

The cancer growth suppressing gene mda-7 induces apoptosis selectively in human melanoma cells

1 reference

12 December 2020

bcl-2 antisense therapy chemosensitizes human melanoma in SCID mice

1 reference

12 December 2020

Antiapoptotic bcl-2 and bcl-xL in advanced malignant melanoma

1 reference

12 December 2020

The Bax/Bcl-2 ratio determines the susceptibility of human melanoma cells to CD95/Fas-mediated apoptosis

1 reference

12 December 2020

c-myc antisense oligodeoxynucleotides enhance the efficacy of cisplatin in melanoma chemotherapy in vitro and in nude mice

1 reference

12 December 2020

Expression of oncogenes, tumour suppressor, mismatch repair and apoptosis-related genes in primary and metastatic melanoma cells

1 reference

12 December 2020

Bax-induction gene therapy of pancreatic cancer.

1 reference

12 December 2020

Malignant melanoma arising from nevi, p53, p16, and Bcl-2: expression in benign versus malignant components

1 reference

12 December 2020

Update of diagnostic and prognostic markers in cutaneous malignant melanoma

1 reference

12 December 2020

Current treatment options for malignant melanoma

1 reference

12 December 2020

Intercellular adhesion molecule 1 (ICAM-1) and bcl-2 are differentially expressed in early evolving malignant melanoma.

1 reference

12 December 2020

A novel bispecific antisense oligonucleotide inhibiting both bcl-2 and bcl-xL expression efficiently induces apoptosis in tumor cells.

1 reference

12 December 2020

Telomerase activity and expression of apoptosis and anti-apoptosis regulators in the progression pathway of human melanoma

1 reference

12 December 2020

CREB and its associated proteins act as survival factors for human melanoma cells

1 reference

12 December 2020

Survivin, bcl-2, bax, and bcl-X gene expression in sentinel lymph nodes from melanoma patients.

1 reference

12 December 2020

Bcl-XL is a chemoresistance factor in human melanoma cells that can be inhibited by antisense therapy

1 reference

12 December 2020

Oblimersen Bcl-2 antisense: facilitating apoptosis in anticancer treatment

1 reference

12 December 2020

Expression of CD40, CD44, bcl-2 antigens and rate of cell proliferation on fine needle aspirates from metastatic melanoma

1 reference

12 December 2020

The machinery of programmed cell death.

1 reference

12 December 2020

The genetics of cutaneous melanoma

1 reference

12 December 2020

Report on the Eighth World Congress on Cancers of the Skin 18-21 July 2001, Zurich, Switzerland

1 reference

12 December 2020

Prognostic value of biomarkers in malignant melanoma.

1 reference

12 December 2020

What's new in the treatment of cutaneous melanoma?

1 reference

12 December 2020

Melanocyte biology and its implications for the clinician

1 reference

12 December 2020

p53-Independent induction of apoptosis in human melanoma cells by a bcl-2/bcl-xL bispecific antisense oligonucleotide

1 reference

12 December 2020

Death receptors: signaling and modulation

1 reference

12 December 2020

Expression of c-myc and bcl-2 in primary and advanced cutaneous melanoma

1 reference

12 December 2020

A novel single tetracycline-regulative adenoviral vector for tumor-specific Bax gene expression and cell killing in vitro and in vivo.

1 reference

12 December 2020

Mutated N-ras upregulates Bcl-2 in human melanoma in vitro and in SCID mice

1 reference

12 December 2020

Immunohistochemically detectable bcl-2 expression in metastatic melanoma: association with survival and treatment response

1 reference

12 December 2020

The Bcl-2 protein family: arbiters of cell survival

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1025874502181

1 reference

15 January 2018

Dimensions Publication ID

0 references

1 reference

15 January 2018